摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-hydroxy-5-<2-<4-(2-methylphenyl)-1-piperazinyl>acetyl>benzoate dihydrochloride | 76310-69-5

中文名称
——
中文别名
——
英文名称
methyl 2-hydroxy-5-<2-<4-(2-methylphenyl)-1-piperazinyl>acetyl>benzoate dihydrochloride
英文别名
methyl 2-hydroxy-5-[2-[4-(2-methylphenyl)-1-piperazinyl]acetyl]benzoate dihydrochloride;methyl 2-hydroxy-5-{2-[4-(2-methylphenyl)-1-piperazinyl]acetyl}benzoate dihydrochloride
methyl 2-hydroxy-5-<2-<4-(2-methylphenyl)-1-piperazinyl>acetyl>benzoate dihydrochloride化学式
CAS
76310-69-5
化学式
C21H24N2O4*2ClH
mdl
——
分子量
441.354
InChiKey
JAXDGQMBDIIPIT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.91
  • 重原子数:
    28.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    70.08
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    methyl 2-hydroxy-5-<2-<4-(2-methylphenyl)-1-piperazinyl>acetyl>benzoate dihydrochloride 在 sodium tetrahydroborate 、 sodium methylate 作用下, 以 甲醇 为溶剂, 反应 0.25h, 生成 N-(2,2-dimethylpropyl)-2-hydroxy-5-[1-hydroxy-2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]benzamide
    参考文献:
    名称:
    Salicylamide derivatives related to medroxalol with .alpha.- and .beta.-adrenergic antagonist and antihypertensive activity
    摘要:
    Analogues of medroxalol (1) were prepared in which the carboxamide function, the phenolic hydroxy group, and the aralkylamine side chain were modified. N-alkyl-substituted amide analogues of 1 showed diminishing beta-blocking activity with increasing steric bulk of the alkyl group. This allowed the conclusion that deactivation of the phenolic hydroxy group of 1 by the carbonyl group of the amide function is responsible for the beta-adrenergic antagonistic properties of 1. This conclusion was strengthened by the finding that the phenolic O-methyl analogue 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1hydroxyethyl]-2-methoxybenzamide (13) was found to have enhanced beta-adrenergic blocking activity. The finding that 13 also had decreased alpha-blocking activity compared to 1 indicated that the phenolic hydroxy group of 1 enhances alpha-adrenergic antagonism. The finding that 1 and 13 showed such a large difference in relative alpha- to beta-blocking potency while exhibiting approximately equal antihypertensive activity in spontaneously hypertensive rats was surprising. In indicated that pharmacologic properties other than alpha- and beta-adrenergic blockade may contribute to the antihypertensive activity of medroxalol. One of the analogues in which the aralkylamine side chain of 1 was replaced by a fragment of a known alpha-adrenergic receptor blocker, 2-hydroxy-5-[1-hydroxy-2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]benzamide (22), showed an interesting pharmacologic profile of potential therapeutic usefulness.
    DOI:
    10.1021/jm00135a017
  • 作为产物:
    参考文献:
    名称:
    2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives
    摘要:
    制备了2-羟基-5-(1-羟基-2-哌嗪基乙基)苯甲酸的衍生物,这些衍生物对α和β肾上腺素受体的阻滞作用很有用。此外,这些化合物还可用作解痉和降压药物。
    公开号:
    US04255575A1
点击查看最新优质反应信息